Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 06/30/2025 | 03/31/2025 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 22.11% | 0.00% | 0.00% | -246.37% |
| Total Depreciation and Amortization | 0.00% | 170.35% | 0.00% | 0.00% | 120.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -187.92% | 0.00% | 0.00% | 113.72% |
| Change in Net Operating Assets | 0.00% | -109.91% | 0.00% | 0.00% | -105.34% |
| Cash from Operations | 0.00% | 1.01% | 0.00% | 0.00% | -79.64% |
| Capital Expenditure | 0.00% | 49.45% | 0.00% | 0.00% | 50.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -57.71% | 0.00% | 0.00% | -53.97% |
| Cash from Investing | 0.00% | -58.98% | 0.00% | 0.00% | -55.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -6.42% | 0.00% | 0.00% | -4.95% |
| Issuance of Common Stock | 0.00% | 2,450.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 10.20% | 0.00% | 0.00% | -16.50% |
| Foreign Exchange rate Adjustments | 0.00% | 219.50% | 0.00% | 0.00% | -173.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -75.59% | 0.00% | 0.00% | -247.45% |